Interestingly, aAbs against the negative regulator of p53, MDM2, have been detected in the serums of patients with lung cancer and autoimmune diseases, namely systemic lupus erythematosus (SLE) and Sjogren’s syndrome [34,35,36]. Here, MDM2 is linked to systemic lupus erythematosus.